ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
천식 치료제 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 7.7%로 445억 3,000만 달러로 성장할 것입니다. 예측 기간의 성장은 천식 치료에서 생물학적 제제에 대한 수요 증가, 맞춤형 의료에 대한 관심 증가, 디지털 흡입기 및 스마트 헬스 기술 채택 확대, 소아 천식 유병률 증가, 혁신 치료제 연구개발 투자 증가 등에 기인하는 것으로 분석됩니다. 예측 기간 동안 예상되는 주요 동향으로는 중증 천식에 대한 생물학적 치료법의 발전, 디지털 추적을 특징으로 하는 최첨단 흡입기 기술, 개인화된 천식 관리 전략 수립, 약물전달 시스템의 혁신, 천식 모니터링을 위한 인공지능과 웨어러블 기술의 통합 등이 있습니다.
천식 유병률의 증가는 천식 치료제 시장의 성장을 촉진하는 데 중요한 역할을 하고 있습니다. 천식은 코와 입에서 폐로 공기를 운반하는 통로가 좁아지는 만성질환으로 기도의 염증과 부종을 특징으로 하는 만성질환입니다. 이러한 유병률 증가는 호흡기를 자극하고 천식 발병 위험을 높이는 오염 물질에 대한 노출 증가에 기인합니다. 천식 치료제는 염증을 억제하고 증상을 완화하며 천식 발작을 예방하여 천식 상태를 관리하는 데 사용됩니다. 흡입용 코르티코스테로이드와 같은 장기적인 관리 약물은 지속적인 염증을 최소화하는 데 도움이 되며, 기관지확장제와 같은 즉각적인 치료는 급성 에피소드 발생 시 즉각적인 증상 완화에 도움이 됩니다. 예를 들어, 2024년 4월 호흡기질환 환자를 지원하는 영국의 자선단체인 Asthma+Lung UK는 영국의 천식 관련 사망자가 2021년 1,146명에서 2022년 1,236명으로 증가했다고 보고했습니다. 이러한 통계는 천식 부담의 증가가 어떻게 치료제 시장의 수요를 촉진하고 있는지를 뒷받침합니다.
천식 치료제 업계의 주요 기업들은 치료 효과를 높이고 환자의 순응도를 높이기 위해 복합제(FDC) 의약품 개발을 통한 혁신에 집중하고 있습니다. FDC 의약품은 흡입기나 정제 등 단일 제형에 두 가지 이상의 유효 의약품 성분을 배합하여 특정 질환을 보다 효율적으로 치료할 수 있는 의약품입니다. 예를 들어, 2022년 6월 인도 제약회사 글렌마크 파마슈티컬스(Glenmark Pharmaceuticals Limited)는 인다카테롤과 모메타존을 결합한 새로운 천식 치료용 FDC 약물을 발표했습니다. 인다카테롤은 기도 근육을 이완시키는 장시간 작용하는 베타 작용제이며, 모메타손은 폐의 염증을 억제하는 흡입용 코르티코스테로이드입니다. 이 1일 1회 투여 FDC 요법은 중등도 및 중증 천식 환자의 복약 순응도를 개선하고 증상 조절 및 편의성을 향상시키기 위해 고안된 치료제입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 천식 치료제 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 천식 치료제 시장 : 성장률 분석
세계의 천식 치료제 시장 실적 : 규모와 성장, 2019-2024
세계의 천식 치료제 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 천식 치료제 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 천식 치료제 시장 : 약물 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
흡입 코르티코스테로이드(ICS)
장시간 작용형 β자극제(LABA)
류코트리엔 수용체 길항제(LTRA)
단시간 작용형 베타 자극제(SABA)
생물학적 제제
배합 흡입기(ICS+LABA)
세계의 천식 치료제 시장 치료 단계별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
급성기 치료
장기 관리
예방 치료
유지 요법
구급약
세계의 천식 치료제 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구
흡입
정맥내
피하
세계의 천식 치료제 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원 약국
소매 약국
온라인 약국
세계의 천식 치료제 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
홈케어
전문 클리닉
세계의 천식 치료제 시장 : 하위 세분화 흡입 코르티코스테로이드(ICS), 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
Fluticasone
Budesonide
Beclomethasone
Mometasone
Ciclesonide
세계의 천식 치료제 시장 : 하위 세분화 장시간 작용형 β자극제(LABA), 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
Salmeterol
Formoterol
Indacaterol
Olodaterol
세계의 천식 치료제 시장 : 하위 세분화 류코트리엔 수용체 길항제(LTRA), 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
Montelukast
Zafirlukast
Pranlukast
세계의 천식 치료제 시장 : 하위 세분화 단시간 작용형 β자극제(SABA), 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
Albuterol (Salbutamol)
Levalbuterol
Terbutaline
세계의 천식 치료제 시장 : 하위 세분화 생물학적 제제(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
Omalizumab
Mepolizumab
Benralizumab
Dupilumab
Reslizumab
세계의 천식 치료제 시장 : 하위 세분화 배합 흡입기(ICS+LABA), 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
Fluticasone + Salmeterol
Budesonide + Formoterol
Mometasone + Indacaterol
Beclomethasone + Formoterol
제7장 지역별·국가별 분석
세계의 천식 치료제 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 천식 치료제 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
천식 치료제 시장 : 경쟁 구도
천식 치료제 시장 : 기업 개요
Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Novartis AG
GlaxoSmithKline plc
Takeda Pharmaceutical Company Limited
Amgen Inc.
Boehringer Ingelheim GmbH
Teva Pharmaceutical Industries Ltd.
Regeneron Pharmaceuticals Inc.
Astellas Pharma Inc.
Vertex Pharmaceuticals Incorporated
Sun Pharmaceutical Industries Ltd.
Chiesi Farmaceutici S.p.A.
Cipla Limited
Mundipharma International Limited
ALK-Abello
Mylan N.V.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
천식 치료제 시장 2029 : 새로운 기회를 제공하는 국가
천식 치료제 시장 2029 : 새로운 기회를 제공하는 부문
천식 치료제 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
Asthma therapeutics refers to the various medications and treatment methods used to manage and alleviate asthma symptoms, a chronic respiratory disease marked by airway inflammation and constriction. These treatments include fast-acting medications for immediate symptom relief and long-term control drugs that reduce airway inflammation and help prevent asthma episodes.
The primary drug classes involved in asthma therapeutics include inhaled corticosteroids (ICS), long-acting beta agonists, leukotriene receptor antagonists, short-acting beta agonists, biologics, and combination inhalers. Inhaled corticosteroids are drugs inhaled directly into the lungs to decrease inflammation and swelling in the airways, improving breathing for asthma patients. These are used at different stages of treatment, such as acute care, long-term management, preventive therapy, maintenance routines, and emergency relief, and are administered through various routes including oral, inhaled, intravenous, and subcutaneous methods. They are distributed through multiple channels such as hospital pharmacies, retail pharmacies, and online pharmacies, and are used by different end-users, including hospitals, home care settings, and specialty clinics.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The asthma therapeutics market research report is one of a series of new reports from The Business Research Company that provides asthma therapeutics market statistics, including asthma therapeutics industry global market size, regional shares, competitors with an asthma therapeutics market share, detailed asthma therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the asthma therapeutics industry. The asthma therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The asthma therapeutics market size has grown strongly in recent years. It will grow from $30.63 billion in 2024 to $33.11 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth during the historic period can be attributed to increased awareness regarding asthma management, greater use of inhalers and nebulizers, a rising incidence of allergic asthma linked to pollution, enhanced government initiatives focused on respiratory health, and the expansion of healthcare infrastructure in developing economies.
The asthma therapeutics market size is expected to see strong growth in the next few years. It will grow to $44.53 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to the increasing demand for biologics in asthma care, a heightened focus on personalized medicine, the growing adoption of digital inhalers and smart health technologies, a rising incidence of pediatric asthma, and increased investments in research and development for innovative therapeutics. Key trends expected during the forecast period include advancements in biologic treatments for severe asthma, cutting-edge inhaler technologies featuring digital tracking, the creation of personalized asthma management strategies, innovations in drug delivery systems, and the integration of artificial intelligence and wearable technology for asthma monitoring.
The rising prevalence of asthma is playing a key role in driving the growth of the asthma therapeutics market. Asthma is a chronic condition characterized by inflammation and swelling of the airways, which leads to narrowing of the passages that carry air from the nose and mouth to the lungs. This growing prevalence is largely attributed to increasing exposure to pollutants, which irritate the airways and elevate the risk of developing asthma. Asthma therapeutics are used to manage the condition by reducing inflammation, relieving symptoms, and preventing asthma attacks. Long-term control medications such as inhaled corticosteroids help minimize persistent inflammation, while quick-relief treatments like bronchodilators provide immediate symptom relief during acute episodes. For example, in April 2024, Asthma + Lung UK, a charity organization in England that supports individuals with respiratory conditions, reported that asthma-related deaths in England rose from 1,146 in 2021 to 1,236 in 2022. These statistics underscore how the increasing burden of asthma is fueling demand in the therapeutics market.
Leading companies in the asthma therapeutics industry are focusing on innovation by developing fixed-dose combination (FDC) drugs to enhance treatment effectiveness and boost patient compliance. An FDC drug contains two or more active pharmaceutical ingredients combined in a single formulation, such as an inhaler or tablet, to target specific conditions more efficiently. For instance, in June 2022, Glenmark Pharmaceuticals Limited, an Indian pharmaceutical company, introduced a new FDC drug combining Indacaterol and Mometasone for asthma treatment. Indacaterol is a long-acting beta-agonist that relaxes the airway muscles, while Mometasone is an inhaled corticosteroid that reduces inflammation in the lungs. This once-daily FDC therapy is designed to provide better symptom control and convenience, improving adherence among patients with moderate to severe asthma.
In March 2022, Sandoz Group AG, a Switzerland-based pharmaceutical company, acquired Coalesce Product Development Limited for an undisclosed sum. This acquisition was aimed at strengthening Sandoz's position in the respiratory market and expanding its expertise in developing inhalation drug-delivery systems. The move is expected to support the company's growth in asthma and other respiratory therapeutic areas. Coalesce Product Development Limited is a UK-based company, specializes in the design and development of medical devices and drug delivery systems tailored for respiratory conditions, including asthma.
Major players in the asthma therapeutics market are Roche Holding AG, Merck & Co Inc., Pfizer Inc., AstraZeneca plc, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Vertex Pharmaceuticals Incorporated, Sun Pharmaceutical Industries Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited, Mundipharma International Limited, ALK-Abello, Mylan N.V., Whanin Pharmaceutical, Mitsubishi Tanabe Pharma, Allergan plc.
North America was the largest region in the asthma therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in asthma therapeutics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the asthma therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The asthma therapeutics market consists of revenues earned by entities by providing services such as prescription management, inhaler technique training, nebulization therapy, and allergy testing and immunotherapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The asthma therapeutics market consists of sales of methylxanthines, anticholinergics, systemic corticosteroids, mast cell stabilizers, immunotherapy products, and adjunctive therapies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Asthma Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on asthma therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for asthma therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The asthma therapeutics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Asthma Therapeutics Market Characteristics
3. Asthma Therapeutics Market Trends And Strategies
4. Asthma Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Asthma Therapeutics Growth Analysis And Strategic Analysis Framework
5.1. Global Asthma Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Asthma Therapeutics Market Growth Rate Analysis
5.4. Global Asthma Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Asthma Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Asthma Therapeutics Total Addressable Market (TAM)
6. Asthma Therapeutics Market Segmentation
6.1. Global Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inhaled Corticosteroids (ICS)
Long-Acting Beta Agonists (LABA)
Leukotriene Receptor Antagonists (LTRA)
Short-Acting Beta Agonists (SABA)
Biologics
Combination Inhalers (ICS + LABA)
6.2. Global Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acute Treatment
Long-Term Control
Preventive Treatment
Maintenance Regimens
Rescue Medications
6.3. Global Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Inhaled
Intravenous
Subcutaneous
6.4. Global Asthma Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.5. Global Asthma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Specialty Clinics
6.6. Global Asthma Therapeutics Market, Sub-Segmentation Of Inhaled Corticosteroids (ICS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fluticasone
Budesonide
Beclomethasone
Mometasone
Ciclesonide
6.7. Global Asthma Therapeutics Market, Sub-Segmentation Of Long-Acting Beta Agonists (LABA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Salmeterol
Formoterol
Indacaterol
Olodaterol
6.8. Global Asthma Therapeutics Market, Sub-Segmentation Of Leukotriene Receptor Antagonists (LTRA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Montelukast
Zafirlukast
Pranlukast
6.9. Global Asthma Therapeutics Market, Sub-Segmentation Of Short-Acting Beta Agonists (SABA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Albuterol (Salbutamol)
Levalbuterol
Terbutaline
6.10. Global Asthma Therapeutics Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Omalizumab
Mepolizumab
Benralizumab
Dupilumab
Reslizumab
6.11. Global Asthma Therapeutics Market, Sub-Segmentation Of Combination Inhalers (ICS + LABA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fluticasone + Salmeterol
Budesonide + Formoterol
Mometasone + Indacaterol
Beclomethasone + Formoterol
7. Asthma Therapeutics Market Regional And Country Analysis
7.1. Global Asthma Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Asthma Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Asthma Therapeutics Market
9.1. China Asthma Therapeutics Market Overview
9.2. China Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Asthma Therapeutics Market
10.1. India Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Asthma Therapeutics Market
11.1. Japan Asthma Therapeutics Market Overview
11.2. Japan Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Asthma Therapeutics Market
12.1. Australia Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Asthma Therapeutics Market
13.1. Indonesia Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Asthma Therapeutics Market
14.1. South Korea Asthma Therapeutics Market Overview
14.2. South Korea Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Asthma Therapeutics Market
15.1. Western Europe Asthma Therapeutics Market Overview
15.2. Western Europe Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Asthma Therapeutics Market
16.1. UK Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Asthma Therapeutics Market
17.1. Germany Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Asthma Therapeutics Market
18.1. France Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Asthma Therapeutics Market
19.1. Italy Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Asthma Therapeutics Market
20.1. Spain Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Asthma Therapeutics Market
21.1. Eastern Europe Asthma Therapeutics Market Overview
21.2. Eastern Europe Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Asthma Therapeutics Market
22.1. Russia Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Asthma Therapeutics Market
23.1. North America Asthma Therapeutics Market Overview
23.2. North America Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Asthma Therapeutics Market
24.1. USA Asthma Therapeutics Market Overview
24.2. USA Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Asthma Therapeutics Market
25.1. Canada Asthma Therapeutics Market Overview
25.2. Canada Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Asthma Therapeutics Market
26.1. South America Asthma Therapeutics Market Overview
26.2. South America Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Asthma Therapeutics Market
27.1. Brazil Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Asthma Therapeutics Market
28.1. Middle East Asthma Therapeutics Market Overview
28.2. Middle East Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Asthma Therapeutics Market
29.1. Africa Asthma Therapeutics Market Overview
29.2. Africa Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Asthma Therapeutics Market Competitive Landscape And Company Profiles
